Doxorubicin Hydrochloride and Cyclophosphamide Followed by Paclitaxel With or Without Carboplatin in Treating Patients With Triple-Negative Breast Cancer
Summary
The registered summary isn't in our current data snapshot. Read it on the ClinicalTrials.gov record ↗. Why? →
Investigators
The overall officials registered on this study. Names that resolve to a findmyKOL profile link to it; the rest are shown as registered.
- Vicente Valero
NRG Oncology
Principal Investigator
A profile link is shown only when the registered name resolves to a person record with a confident, namesake-checked match; ambiguous names stay unlinked.
Sites
1,296 registered facilities, with the per-site recruitment status where the registry publishes one. ClinicalTrials.gov does not publish per-site enrollment counts.
- Tom Baker Cancer Centre
Calgary, Alberta, Canada
- Health Sciences North
Greater Sudbury, Ontario, Canada
- Chum - Centre Hospitalier de L'Universite de Montreal
Montreal, Quebec, Canada
- Chum - Hopital Notre-Dame
Montreal, Quebec, Canada
- Chum-Hotel Dieu de Montreal
Montreal, Quebec, Canada
- Jewish General Hospital
Montreal, Quebec, Canada
- Mcgill University Department of Oncology
Montreal, Quebec, Canada
- the Research Institute of the Mcgill University Health Centre (muhc)
Montreal, Quebec, Canada
- Centre Hospitalier Universitaire de Sherbrooke-Fleurimont
Sherbrooke, Quebec, Canada
- Allan Blair Cancer Centre
Regina, Saskatchewan, Canada
- Southern Cancer Center Pc-Mobile
Mobile, Alabama, United States
- Southern Cancer Center Pc-Providence
Mobile, Alabama, United States
- Southern Cancer Center Pc-Springhill
Mobile, Alabama, United States
- Alaska Breast Care and Surgery Llc
Anchorage, Alaska, United States
- Alaska Oncology and Hematology Llc
Anchorage, Alaska, United States
- Alaska Regional Hospital
Anchorage, Alaska, United States
- Alaska Women'S Cancer Care
Anchorage, Alaska, United States
- Anchorage Associates in Radiation Medicine
Anchorage, Alaska, United States
- Anchorage Oncology Centre
Anchorage, Alaska, United States
- Anchorage Radiation Therapy Center
Anchorage, Alaska, United States
- Katmai Oncology Group
Anchorage, Alaska, United States
- Providence Alaska Medical Center
Anchorage, Alaska, United States
- Fairbanks Memorial Hospital
Fairbanks, Alaska, United States
- Arizona Breast Cancer Specialists-Gilbert
Gilbert, Arizona, United States
- Virginia G Piper Cancer Care-Glendale
Glendale, Arizona, United States
- Ctca at Western Regional Medical Center
Goodyear, Arizona, United States
- Arizona Center for Cancer Care-Peoria
Peoria, Arizona, United States
- Arizona Breast Cancer Specialists-Phoenix
Phoenix, Arizona, United States
- Arizona Oncology Associates-Biltmore Cancer Center
Phoenix, Arizona, United States
- Arizona Oncology-Deer Valley Center
Phoenix, Arizona, United States
- Arizona Breast Cancer Specialists
Scottsdale, Arizona, United States
- Arizona Breast Cancer Specialists-Scottsdale
Scottsdale, Arizona, United States
- Oncogyne Pc-Arizona Oncology
Scottsdale, Arizona, United States
- Virginia G Piper Cancer Care-del Camino
Scottsdale, Arizona, United States
- Sedona Medical Center
Sedona, Arizona, United States
- Arizona Center for Cancer Care-Surprise
Surprise, Arizona, United States
- Mercy Hospital Fort Smith
Fort Smith, Arkansas, United States
- Chi Saint Vincent Cancer Center Hot Springs
Hot Springs, Arkansas, United States
- Baptist Memorial Hospital and Fowler Family Cancer Center - Jonesboro
Jonesboro, Arkansas, United States
- University of Arkansas for Medical Sciences
Little Rock, Arkansas, United States
Site investigator names are published by ClinicalTrials.gov only while a study recruits, so completed studies list sites without them.
Drugs studied
No drug or biological interventions are in our data for this study — it may test a procedure, device or behavioral intervention, or the intervention list isn't in our current snapshot. See the registry record ↗. Why? →
Registration & key dates
Registry attributes as recorded on the ClinicalTrials.gov study record.
- Start
- 26 Jul 2015
- Primary completion
- 31 Dec 2025
- Completion
- 31 Oct 2026
- Last update posted
- 6 May 2026
- Registered enrollment
- 782
- Registry id
- NCT02488967
Cross-registrations
Source: ClinicalTrials.gov, via the CTTI AACT database, data as of 12 Jul 2026. Registry facts are shown as registered by the study sponsor; findmyKOL does not interpret them.